OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
600684 Guangzhou Pearl River Development Group co.,Ltd.
- 3.45
- +0.04+1.17%
Not Open Apr 1 15:00 CST
2.94BMarket Cap191.67P/E (TTM)
3.49High3.42Low103.14KlotVolume3.42Open3.41Pre Close35.65MTurnover1.21%Turnover Ratio191.67P/E (Static)853.46MShares4.0352wk High6.40P/B2.94BFloat Cap2.5052wk Low3.75Limit Up853.46MShs Float17.18Historical High3.07Limit Down2.05%Amplitude0.14Historical Low--Dividend TTM3.46Avg Price54.19KlotAsk--Div YieldTTM100Lot Size48.65KlotBid
Guangzhou Pearl River Development Group co.,Ltd. Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -52.38%1.56B | -59.81%1.13B | -72.89%663.48M | -84.74%322.41M | -35.58%3.27B | 72.95%2.81B | 203.37%2.45B | 469.19%2.11B | 6.30%5.08B | -29.04%1.63B |
| Operating revenue | -52.38%1.56B | -59.81%1.13B | -72.89%663.48M | -84.74%322.41M | -35.58%3.27B | 72.95%2.81B | 203.37%2.45B | 469.19%2.11B | 6.30%5.08B | -29.04%1.63B |
| Other operating revenue | -94.45%3.32M | ---- | -98.09%94.75K | ---- | 104.81%59.75M | ---- | 6.83%4.96M | ---- | --29.17M | ---- |
| Total operating cost | -54.45%1.47B | -61.69%1.07B | -74.22%628.55M | -85.30%308.16M | -40.27%3.23B | 37.62%2.8B | 138.38%2.44B | 329.81%2.1B | 23.95%5.42B | 4.82%2.04B |
| Operating cost | -54.34%1.24B | -61.92%910.57M | -74.92%527.53M | -85.91%258.73M | -37.30%2.72B | 76.06%2.39B | 248.87%2.1B | 581.98%1.84B | 42.61%4.34B | 16.22%1.36B |
| Operating tax surcharges | -73.26%21.52M | -66.94%18.86M | -92.65%4.02M | -96.20%1.99M | -64.54%80.5M | -48.08%57.06M | -1.17%54.77M | 243.66%52.48M | -44.03%226.99M | -64.01%109.88M |
| Operating expense | -81.66%12.54M | -80.51%12.33M | -86.51%7.93M | -92.20%4.38M | -57.15%68.36M | -37.30%63.29M | 38.15%58.78M | 139.22%56.13M | 10.86%159.51M | 19.38%100.94M |
| Administration expense | -25.75%160.6M | -37.37%105.57M | -46.18%70.63M | -61.93%34.39M | -35.30%216.3M | -23.24%168.55M | -11.04%131.22M | 8.54%90.35M | -20.63%334.3M | 66.49%219.58M |
| Financial expense | -81.46%24.96M | -82.63%20.13M | -83.40%14.15M | -89.13%6.5M | -60.82%134.64M | -53.21%115.88M | -51.12%85.24M | -38.18%59.77M | -2.39%343.63M | -2.00%247.68M |
| -Interest expense (Financial expense) | -83.66%29.28M | -83.15%24.08M | -83.43%17.55M | -85.50%9.29M | -50.71%179.15M | -45.40%142.88M | -38.54%105.89M | -40.57%64.06M | -5.94%363.45M | -0.99%261.67M |
| -Interest Income (Financial expense) | 89.31%-6.34M | 86.77%-5.46M | 84.82%-4.37M | 47.08%-3.27M | -19.88%-59.29M | -5.97%-41.25M | -27.41%-28.77M | 82.76%-6.18M | 17.32%-49.46M | -30.76%-38.92M |
| Research and development | -9.15%9.78M | -12.54%6.31M | -9.31%4.29M | -2.90%2.16M | 66.69%10.77M | 1,205.36%7.21M | --4.73M | --2.23M | --6.46M | --552.66K |
| Credit Impairment Loss | -364.84%-35.98M | -0.64%-11.41M | -2.60%-5.76M | -4,679.01%-2.33M | 97.19%-7.74M | 85.11%-11.33M | 85.86%-5.61M | -113.30%-48.86K | -35.63%-275.52M | -495.54%-76.1M |
| Asset Impairment Loss | 99.66%-28.21K | ---28.21K | ---28.21K | ---27.24K | 99.40%-8.23M | ---- | ---- | ---- | -143,068.76%-1.37B | -1,011,233.30%-1.29B |
| Other net revenue | -503.92%-43.73M | -6,775.07%-25.46M | -3,743.77%-31.82M | -278.21%-13.42M | 99.56%-7.24M | 100.03%381.45K | 99.87%-827.95K | 333.22%7.53M | -848.46%-1.66B | -10,595.79%-1.4B |
| Fair value change income | -343.79%-20.01M | -1,543.59%-18.13M | -682.58%-29.44M | -922.70%-11.08M | 83.60%-4.51M | 103.65%1.26M | 86.75%-3.76M | 122.10%1.35M | -198.50%-27.5M | -766.79%-34.4M |
| Invest income | 113.15%3.23M | 52.45%1.63M | 43.00%1.52M | -180.23%-974.38K | 166.88%1.52M | 110.15%1.07M | 109.46%1.07M | 3,836.57%1.21M | 63.50%-2.27M | -57.10%-10.51M |
| -Including: Investment income associates | 168.72%2.53M | 91.33%954.89K | 73.44%865.59K | -172.69%-974.38K | -87.25%941.81K | 171.42%499.09K | 134.97%499.09K | 794.58%1.34M | 133.90%7.39M | 96.65%-698.77K |
| Asset deal income | -8.60%2.55M | -92.47%192.14K | -92.82%184.04K | -97.33%68.81K | 80.61%2.79M | 60.87%2.55M | 65.32%2.56M | 230.15%2.57M | 942.96%1.55M | 6,154.30%1.59M |
| Other revenue | -27.12%6.5M | -66.62%2.28M | -65.56%1.69M | -61.92%930.41K | -15.22%8.92M | -17.13%6.84M | 2.85%4.92M | 44.77%2.44M | 47.19%10.53M | 655.71%8.25M |
| Operating profit | 35.22%41.17M | 169.60%32M | -64.52%3.11M | -96.53%829.89K | 101.53%30.45M | 100.66%11.87M | 101.00%8.76M | 119.98%23.94M | -951.32%-2B | -635.68%-1.81B |
| Add:Non operating Income | -78.88%1.13M | -78.05%762.06K | -82.82%592.68K | -76.98%341.58K | -65.41%5.36M | -65.79%3.47M | 13.88%3.45M | 11.30%1.48M | 266.92%15.5M | 338.73%10.15M |
| Less:Non operating expense | 10.74%2.08M | -36.91%1.28M | -14.80%965.65K | -51.62%153.47K | -58.05%1.88M | -31.04%2.04M | -47.13%1.13M | -60.43%317.23K | 45.40%4.49M | 86.88%2.95M |
| Total profit | 18.55%40.22M | 136.59%31.48M | -75.30%2.74M | -95.94%1.02M | 101.71%33.93M | 100.74%13.3M | 101.27%11.08M | 121.04%25.1M | -942.53%-1.99B | -632.39%-1.8B |
| Less:Income tax cost | -58.98%20.16M | -69.36%12.56M | -76.78%7.48M | -89.55%3M | -53.44%49.14M | 241.62%40.99M | 306.23%32.21M | 291.75%28.7M | -27.13%105.54M | -122.94%-28.95M |
| Net profit | 231.80%20.06M | 168.33%18.92M | 77.56%-4.74M | 44.96%-1.98M | 99.27%-15.22M | 98.44%-27.69M | 97.54%-21.13M | 97.16%-3.6M | -2,402.75%-2.09B | -935.73%-1.77B |
| Net profit from continuing operation | 231.80%20.06M | 168.33%18.92M | 77.56%-4.74M | 44.96%-1.98M | 99.27%-15.22M | 98.44%-27.69M | 97.54%-21.13M | 97.16%-3.6M | -2,354.77%-2.09B | -928.18%-1.77B |
| Less:Minority Profit | -90.61%4.48M | -96.72%1.58M | -96.90%1.5M | -98.83%556.82K | 116.28%47.74M | 115.59%48.19M | 145.80%48.17M | 532.26%47.52M | -811.03%-293.34M | -695.17%-309.15M |
| Net profit of parent company owners | 124.74%15.57M | 122.85%17.34M | 91.00%-6.24M | 95.03%-2.54M | 96.50%-62.96M | 94.81%-75.88M | 90.79%-69.3M | 55.78%-51.12M | -1,561.44%-1.8B | -682.86%-1.46B |
| Earning per share | ||||||||||
| Basic earning per share | 128.57%0.02 | 122.22%0.02 | 87.50%-0.01 | --0 | 96.68%-0.07 | 94.74%-0.09 | 90.91%-0.08 | 57.14%-0.06 | -1,607.14%-2.11 | -689.66%-1.71 |
| Diluted earning per share | 128.57%0.02 | 122.22%0.02 | 87.50%-0.01 | --0 | 96.68%-0.07 | 94.74%-0.09 | 90.91%-0.08 | 57.14%-0.06 | -1,607.14%-2.11 | -689.66%-1.71 |
| Other composite income | -98.59%232.73K | -98.74%199.95K | -99.51%77.66K | -49.72%16.51M | 15.92M | 15.92M | 327.17%32.83M | |||
| Other composite income of parent company owners | -98.59%232.73K | -98.74%199.95K | -99.51%77.66K | ---- | -49.72%16.51M | --15.92M | --15.92M | ---- | 327.17%32.83M | ---- |
| Total composite income | 1,476.06%20.29M | 262.48%19.12M | 10.47%-4.66M | 44.96%-1.98M | 100.06%1.29M | 99.34%-11.77M | 99.39%-5.21M | 97.16%-3.6M | -2,795.58%-2.06B | -935.73%-1.77B |
| Total composite income of parent company owners | 134.03%15.81M | 129.25%17.54M | 88.46%-6.16M | 95.03%-2.54M | 97.37%-46.45M | 95.90%-59.96M | 92.91%-53.38M | 55.78%-51.12M | -1,725.89%-1.76B | -682.86%-1.46B |
| Total composite income of minority owners | -90.61%4.48M | -96.72%1.58M | -96.90%1.5M | -98.83%556.82K | 116.28%47.74M | 115.59%48.19M | 145.80%48.17M | 532.26%47.52M | -811.23%-293.32M | -695.17%-309.15M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.